Which are the causes of Glycogen Storage Disease?

Glycogen Storage Disease (GSD) is a group of inherited metabolic disorders caused by genetic mutations that prevent the body from properly storing or breaking down glycogen, a complex sugar used for energy. Because these conditions are caused by specific gene defects, they are present from birth and are not triggered by environmental factors or lifestyle choices. Currently, 379 people with Glycogen Storage Disease have joined the DiseaseMaps community to share their experiences and navigate these complex metabolic challenges.

What causes Glycogen Storage Disease at the genetic level?

At its core, Glycogen Storage Disease is caused by a deficiency in one of the specific enzymes responsible for converting glycogen into glucose (blood sugar) or managing its structure. Think of glycogen as a "savings account" of energy in your liver and muscles. In a healthy person, the body makes withdrawals from this account whenever energy is needed. In patients with Glycogen Storage Disease, the "bank teller" (the enzyme) is either missing, broken, or working too slowly, which leads to either an accumulation of unusable glycogen or an inability to access energy when the body is fasting.

Is Glycogen Storage Disease hereditary?

Yes, Glycogen Storage Disease is strictly a genetic condition. It is inherited through a pattern known as autosomal recessive inheritance in the vast majority of cases. This means that a child must inherit one mutated gene from each parent to develop the disorder. Parents who carry only one copy of the mutated gene are typically asymptomatic "carriers" who do not know they have the trait until they have a child with the condition. Because it is encoded in your DNA, there are no environmental triggers, infections, or autoimmune processes that cause Glycogen Storage Disease.

How are the different types of Glycogen Storage Disease categorized?

There are over 10 distinct types of Glycogen Storage Disease, each named based on the specific enzyme deficiency and the organ system primarily affected. The medical community uses a classification system to distinguish them:

• Type I (Von Gierke disease): Caused by a deficiency in glucose-6-phosphatase; affects the liver and kidneys.


• Type II (Pompe disease): Caused by a deficiency in acid alpha-glucosidase; primarily affects the heart and skeletal muscles.


• Type III (Cori disease): Caused by a deficiency in the glycogen debranching enzyme.


• Type V (McArdle disease): Specifically affects muscle tissue due to a deficiency in muscle phosphorylase.

Is the etiology of Glycogen Storage Disease fully understood?

While we have identified the specific genetic mutations for most forms of Glycogen Storage Disease, researchers continue to study the variability in disease severity. Even within the same subtype, two patients with the same genetic mutation may experience different symptoms, suggesting that "modifier genes" or other epigenetic factors may play a role in how the body compensates for the enzyme deficiency. Current research is heavily focused on gene therapy and enzyme replacement therapies, which aim to correct the underlying metabolic imbalance rather than just managing symptoms through diet.

Next steps

• Consult a metabolic specialist or a genetic counselor to confirm your specific subtype through molecular genetic testing.


• Connect with the 379 members of the DiseaseMaps community to learn how others manage their daily energy intake and metabolic monitoring.


• Register with the Association for Glycogen Storage Disease (AGSD) to stay informed about clinical trials and emerging gene therapy research.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment from your healthcare provider.

References

• National Institutes of Health (NIH) - Genetic and Rare Diseases Information Center (GARD).


• Online Mendelian Inheritance in Man (OMIM) database for metabolic enzyme deficiencies.


• Orphanet: Portal for rare diseases and orphan drugs.


• Association for Glycogen Storage Disease (AGSD) clinical resources.